Metraipolis › archive › dc_dc8249b6f3fd

Novel therapeutic strategies targeting mitochondrial quality control for metabolic dysfunction-associated steatotic liver disease — Europe PMC PMID:42369603

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42369603
DOI
10.3389/fphys.2026.1803228
License (as archived)
solo-consultazione
Archived
2026-10-31T13:50:38.875Z
SHA-256 of the archived text
90b8cbe360d1383d2e3c21b373cde5462022f876de7fb56b8a24bd8ef501db88
Stable URL of this page
https://metraipolis.com/documento/dc_dc8249b6f3fd

How to cite

Novel therapeutic strategies targeting mitochondrial quality control for metabolic dysfunction-associated steatotic liver disease — Europe PMC PMID:42369603 — Europe PMC (en), https://europepmc.org/article/MED/42369603 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_dc8249b6f3fd (Metraipolis archive dc_dc8249b6f3fd, sha256 90b8cbe360d1383d2e3c21b373cde5462022f876de7fb56b8a24bd8ef501db88)
BibTeX
@misc{dcdc8249b6f3fd,
  title = {Novel therapeutic strategies targeting mitochondrial quality control for metabolic dysfunction-associated steatotic liver disease — Europe PMC PMID:42369603},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42369603},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_dc8249b6f3fd; sha256 90b8cbe360d1383d2e3c21b373cde5462022f876de7fb56b8a24bd8ef501db88},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42369603. Agents can read the archived copy with the MCP tool read_document.